PLEK2 was found to show upregulation in HNSCC and even in HNSCC subgroups based on clinicopathological features including gender, age, race, tumor grade, individual cancer stage, nodal metastasis status, HPV status, TP53 mutation, alcohol, and tobacco smoking history compared to normal tissues. Here, PLEK2 is linked to neoplasm.